With advanced oncology infrastructure, IRCCS Ospedale Galeazzi- Sant’Ambrogio offers Targeted Therapy for patients with cancers that contain specific treatable molecular alterations. Established in 1963, the SSN accredited hospital is located in milan, Italy, and has 560 beds.

Targeted medicines may block signals that allow cancer cells to grow, divide, spread, or develop new blood vessels. The choice of therapy depends on the cancer type, stage, molecular profile, and previous treatments. Comprehensive diagnostic and biomarker testing is performed when appropriate to guide treatment selection.